1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [
DOI:10.3322/caac.21492] [
PMID]
2. Laing-Aiken Z, Ooi S, Mylvaganam G, Xie H, Ludlow J, Pather S. Grade 3 endometrioid adenocarinoma of the lower uterine segment diagnosed 6 weeks after a term delivery: A case report and literature review. Gynecol Oncol Rep. 2021;38:100884. [
DOI:10.1016/j.gore.2021.100884] [
PMID] [
PMCID]
3. Shiomi M, Matsuzaki S, Kobayashi E, Hara T, Nakagawa S, Takiuchi T, et al. Endometrial carcinoma in a gravid uterus: a case report and literature review. BMC Pregnancy Childbirth. 2019;19(1):425. [
DOI:10.1186/s12884-019-2489-y] [
PMID] [
PMCID]
4. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, Schoenmakers EFPM, Vergote I. Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol. 2003;91(1):265-71. [
DOI:10.1016/S0090-8258(03)00477-3] [
PMID]
5. Talayeh M, Arab M, Noei Teymoordash S, Afsharmoghadam N, Raoufi M, Ghavami B, Asghari M. Low-Grade Endometrial Stromal Sarcoma in a Young Woman: A Case Report. J Obstet Gynecol Cancer Res. 2022;7(6):569-73. [
DOI:10.30699/jogcr.7.6.569]
6. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999-1012. [
DOI:10.1016/j.bpobgyn.2008.08.004] [
PMID]
8. Goh C, Mathur M, Lim-Tan SK, Lim YK. Endometrial Hyperplasia as a Cause of Secondary Postpartum Hemorrhage in a Post Caesarean Section Patient. J Med Cases. 2018;9(6):183-6. [
DOI:10.14740/jmc3064w]
10. Yokoyama Y, Suzuki M, Sato Y, Iwagaki S, Takahashi Y, Iwata H. A Case of Undifferentiated Carcinoma in a 2-Month Postpartum Reproductive Tract with a Rapid and Fulminant Course. Case Rep Obstet Gynecol. 2021;2021:3516646. [
DOI:10.1155/2021/3516646] [
PMID] [
PMCID]
11. Roškar L, Roškar I, Rižner TL, Smrkolj Š. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer. Biomolecules. 2022;12(1):7. [
DOI:10.3390/biom12010007] [
PMID] [
PMCID]
12. Doldi N, Bassan M, Gulisano M, Broccoli V, Boncinelli E, Ferrari A. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. J Gynaecol Endocrinol. 1996;10(6):375-82. [
DOI:10.3109/09513599609023600] [
PMID]
13. Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 1996;78(3):454-60. [
DOI:10.1002/(SICI)1097-0142(19960801)78:33.0.CO;2-Y]
15. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol. 2000;24(9):1201-8. [
DOI:10.1097/00000478-200009000-00002] [
PMID]
17. Vaccarello L, Apte SM, Copeland LJ, Boutselis JG, Rubin SC. Endometrial Carcinoma Associated with Pregnancy: A Report of Three Cases and Review of the Literature. Gynecol Oncol. 1999;74(1):118-22. [
DOI:10.1006/gyno.1999.5369] [
PMID]